| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
9,450 |
8,810 |
$139K |
| 80061 |
Lipid panel |
8,280 |
7,603 |
$105K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,223 |
12,818 |
$94K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,529 |
2,267 |
$85K |
| 80053 |
Comprehensive metabolic panel |
8,168 |
7,480 |
$75K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,845 |
2,578 |
$69K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,863 |
1,675 |
$50K |
| 36415 |
Collection of venous blood by venipuncture |
5,546 |
4,378 |
$41K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,514 |
3,196 |
$32K |
| 81001 |
|
11,101 |
10,133 |
$31K |
| 86328 |
|
1,362 |
1,310 |
$26K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,227 |
2,967 |
$25K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
741 |
712 |
$24K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
638 |
632 |
$20K |
| 86703 |
|
1,554 |
1,447 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
364 |
344 |
$18K |
| 84153 |
|
976 |
886 |
$16K |
| 87088 |
|
2,090 |
1,872 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,086 |
1,865 |
$15K |
| 82043 |
|
2,553 |
2,318 |
$13K |
| 82274 |
|
942 |
928 |
$13K |
| 80074 |
|
221 |
198 |
$10K |
| 84436 |
|
1,615 |
1,558 |
$10K |
| 87184 |
|
1,504 |
1,335 |
$9K |
| 84439 |
|
989 |
873 |
$8K |
| 82607 |
|
506 |
417 |
$7K |
| 87276 |
|
543 |
446 |
$7K |
| 87275 |
|
543 |
446 |
$6K |
| 80050 |
General health panel |
577 |
575 |
$6K |
| 86738 |
|
442 |
362 |
$5K |
| 84479 |
|
950 |
928 |
$5K |
| 86592 |
|
1,177 |
1,090 |
$5K |
| 84460 |
|
925 |
909 |
$4K |
| 84450 |
|
866 |
850 |
$4K |
| 82947 |
|
937 |
916 |
$3K |
| 85651 |
|
1,008 |
843 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
52 |
51 |
$3K |
| 82570 |
|
359 |
302 |
$2K |
| 86038 |
|
132 |
118 |
$1K |
| 82950 |
|
264 |
252 |
$1K |
| 84478 |
|
192 |
192 |
$987.24 |
| 83655 |
|
75 |
75 |
$843.12 |
| 82465 |
|
212 |
212 |
$829.25 |
| 82565 |
|
185 |
183 |
$812.09 |
| 85730 |
|
121 |
113 |
$655.54 |
| 85610 |
|
150 |
141 |
$533.34 |
| 84550 |
|
110 |
73 |
$490.58 |
| 84481 |
|
25 |
25 |
$398.93 |
| 83001 |
|
16 |
16 |
$279.86 |
| 82272 |
|
65 |
65 |
$245.28 |
| 83002 |
|
12 |
12 |
$210.30 |
| 82951 |
|
18 |
12 |
$205.96 |
| 87177 |
|
27 |
27 |
$191.37 |
| 86803 |
|
12 |
12 |
$135.35 |
| 84703 |
|
15 |
15 |
$106.55 |
| 86886 |
|
12 |
12 |
$59.28 |
| 81000 |
|
16 |
16 |
$46.85 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
66 |
55 |
$0.00 |